Evidence map›Paper›PMID 27004103›Full record

ArticleSkeletal muscle2016

Alterations to mTORC1 signaling in the skeletal muscle differentially affect whole-body metabolism.

Maitea Guridi, Barbara Kupr, Klaas Romanino, Shuo Lin, Denis Falcetta, Lionel Tintignac, Markus A Rüegg

Abstract read
In one paragraph

Article in Skeletal muscle, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. mTORC1 in energy expenditure: consequences for obesity.Nature reviews. Endocrinology · 2024
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Deletion ofJBMR plus · 2021
    Article
  12. Article
  13. Review
  14. A novel voluntary weightlifting model in mice promotes muscle adaptation and insulin sensitivity with simultaneous enhancement of autophagy and mTOR pathway.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Role of mTOR in Glucose and Lipid Metabolism.International journal of molecular sciences · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maitea GuridiBiozentrum, University of Basel, 4056 Basel, Switzerland.
Barbara KuprBiozentrum, University of Basel, 4056 Basel, Switzerland.
Klaas RomaninoBiozentrum, University of Basel, 4056 Basel, Switzerland.
Shuo LinBiozentrum, University of Basel, 4056 Basel, Switzerland.
Denis FalcettaBiozentrum, University of Basel, 4056 Basel, Switzerland.
Lionel TintignacBiozentrum, University of Basel, 4056 Basel, Switzerland ; Present address: Neuromuscular Research Center, Departments of Neurology and Biomedicine, Pharmazentrum, University of Basel, 4056 Basel, Switzerland.
Markus A RüeggBiozentrum, University of Basel, 4056 Basel, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe mammalian target of rapamycin complex 1 (mTORC1) is a central node in a network of signaling pathways controlling cell growth and survival. This multiprotein complex integrates external signals and affects different nutrient pathways in various organs. However, it is not clear how alterations of mTORC1 signaling in skeletal muscle affect whole-body metabolism.

resultsWe characterized the metabolic phenotype of young and old raptor muscle knock-out (RAmKO) and TSC1 muscle knock-out (TSCmKO) mice, where mTORC1 activity in skeletal muscle is inhibited or constitutively activated, respectively. Ten-week-old RAmKO mice are lean and insulin resistant with increased energy expenditure, and they are resistant to a high-fat diet (HFD). This correlates with an increased expression of histone deacetylases (HDACs) and a downregulation of genes involved in glucose and fatty acid metabolism. Ten-week-old TSCmKO mice are also lean, glucose intolerant with a decreased activation of protein kinase B (Akt/PKB) targets that regulate glucose transporters in the muscle. The mice are resistant to a HFD and show reduced accumulation of glycogen and lipids in the liver. Both mouse models suffer from a myopathy with age, with reduced fat and lean mass, and both RAmKO and TSCmKO mice develop insulin resistance and increased intramyocellular lipid content.

conclusionsOur study shows that alterations of mTORC1 signaling in the skeletal muscle differentially affect whole-body metabolism. While both inhibition and constitutive activation of mTORC1 induce leanness and resistance to obesity, changes in the metabolism of muscle and peripheral organs are distinct. These results indicate that a balanced mTORC1 signaling in the muscle is required for proper metabolic homeostasis.

Indexed as

Energy MetabolismAdaptor Proteins, Signal TransducingAge FactorsAnimalsBiomarkersBlood GlucoseBody CompositionDiet, High-FatGenotypeHistone DeacetylasesInsulinInsulin ResistanceMechanistic Target of Rapamycin Complex 1Mice, KnockoutMultiprotein ComplexesMuscle, SkeletalAdaptor Proteins, Signal TransducingBiomarkersBlood GlucoseHistone DeacetylasesInsulinMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesProto-Oncogene Proteins c-aktRegulatory-Associated Protein of mTORRptor protein, mouseTOR Serine-Threonine KinasesTsc1 protein, mouseTuberous Sclerosis Complex 1 ProteinTumor Suppressor ProteinsDiabetesMetabolismmTORMuscleMyopathyRaptorTSC1

Identifiers

PMID27004103
PMCPMC4800774

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.